Autoimmune hepatitis differential diagnosis: Difference between revisions
No edit summary |
|||
Line 48: | Line 48: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +++ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +++ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |HBs Ag, HBc Ab, HBe Ag | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HBsAg|HBs]] Ag, HBc Ab, HBe Ag | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | --- | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | --- | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 62: | Line 62: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+++</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+++</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |HCV Ab | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HCV]] Ab | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 77: | Line 77: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+++</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+++</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |HEV Ab | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[HEV]] Ab | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 91: | Line 91: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>++</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>++</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CMV-specific immunoglobulin (Ig)M antibody | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CMV]]-specific immunoglobulin (Ig)M antibody | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Usually manifests as mononucleosis syndrome | * Usually manifests as [[mononucleosis]] syndrome | ||
* [[fever]] usually present | * [[fever]] usually present | ||
|- | |- | ||
Line 107: | Line 107: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Systemic manifestations as mononucleosis syndrome | * Systemic manifestations as [[mononucleosis]] syndrome | ||
* Fever usually present | * [[Fever]] usually present | ||
|- | |- | ||
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |[[Autoimmune hepatitis]] | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |[[Autoimmune hepatitis]] | ||
Line 132: | Line 132: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* History of alcohol intake | * History of [[alcohol]] intake | ||
|- | |- | ||
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Drug induced hepatitis | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Drug induced hepatitis | ||
Line 144: | Line 144: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* May cause either cholestatic or hepatocellular injury | * May cause either [[cholestatic]] or [[Hepatocellular Disease|hepatocellular]] injury | ||
|- | |- | ||
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Primary biliary cirrhosis | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Primary biliary cirrhosis | ||
Line 154: | Line 154: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+++</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+++</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |anti-mitochondrial antibodies (AMAs) | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anti-mitochondrial antibody|anti-mitochondrial antibodies]] (AMAs) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Liver biopsy is required for diagnosis | * [[Liver biopsy]] is required for diagnosis | ||
|- | |- | ||
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Primary sclerosing cholangitis | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Primary sclerosing cholangitis | ||
Line 168: | Line 168: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |anti-mitochondrial antibodies (AMAs) | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |anti-mitochondrial antibodies (AMAs) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Liver biopsy is required for diagnosis | * [[Liver biopsy]] is required for diagnosis | ||
|} | |} | ||
Revision as of 17:08, 9 January 2018
Autoimmune hepatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Autoimmune hepatitis differential diagnosis On the Web |
American Roentgen Ray Society Images of Autoimmune hepatitis differential diagnosis |
Risk calculators and risk factors for Autoimmune hepatitis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]
Overview
Autoimmune hepatitis must be differentiated from other diseases that cause jaundice, nausea and vomiting, abdominal pain, arthragia, and hepatomegaly such as hepatitis A, B, C, E, drug-induced hepatitis, CMV hepatitis, EBV hepatitis, alcoholic hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis.
Differentiating autoimmune hepatitis from other diseases
Autoimmune hepatitis must be differentiated from other diseases that cause jaundice, nausea and vomiting, abdominal pain, arthragia, and hepatomegaly such as Hepatitis A,B,C, E, drug induced hepatitis, CMV hepatitis, EBV hepatitis, alcoholic hepatitis, Primary biliary cirrhosis and Primary sclerosing cholangitis.[1][2][3][4]
Disease | Clinical manifestations | Laboratory findings | Additional findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | Transaminitis (elevated AST and ALT) | Viral markers | Autoimmune markers | ||||||
Nausea & vomiting | Abdominal pain | Arthralgia | Jaundice | Hepatomegaly | ||||||
Acute viral hepatitis | Hepatitis A | +++ | ++ | + | +++ | + | +++ | HAV Ab | --- |
|
Hepatitis B | +++ | ++ | ++ | +++ | + | +++ | HBs Ag, HBc Ab, HBe Ag | --- |
| |
Hepatitis C | +++ | ++ | ++ | +++ | + | +++ | HCV Ab | --- |
| |
Hepatitis E | ++ | ++ | +/- | ++ | + | +++ | HEV Ab | --- |
| |
CMV hepatitis | +/- | ++ | - | + | + | ++ | CMV-specific immunoglobulin (Ig)M antibody | -- |
| |
EBV hepatitis | +/- | ++ | - | +/- | + | ++ | Heterophile antibody test, monospot test | -- |
| |
Autoimmune hepatitis | - | + | +/- | ++ | + | +++ | --- | ANA, ASMA, anti SLA/LP, ANCA, ALKM-1 antibodies |
| |
Alcoholic hepatitis | +/- | + | - | + | - | AST>ALT | --- | --- |
| |
Drug induced hepatitis | +/- | + | - | + | + | ++ | --- | --- |
| |
Primary biliary cirrhosis | - | + | +/- | ++ | + | +++ | --- | anti-mitochondrial antibodies (AMAs) |
| |
Primary sclerosing cholangitis | - | + | +/- | ++ | + | +++ | --- | anti-mitochondrial antibodies (AMAs) |
|
References
- ↑ Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011). "Primary biliary cirrhosis". Lancet. 377 (9777): 1600–9. doi:10.1016/S0140-6736(10)61965-4. PMID 21529926.
- ↑ Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ (2009). "Primary biliary cirrhosis". Hepatology. 50 (1): 291–308. doi:10.1002/hep.22906. PMID 19554543.
- ↑ Koff RS (1998). "Hepatitis A". Lancet. 351 (9116): 1643–9. doi:10.1016/S0140-6736(98)01304-X. PMID 9620732.
- ↑ Ciocca M (2000). "Clinical course and consequences of hepatitis A infection". Vaccine. 18 Suppl 1: S71–4. PMID 10683554.